Virbac (LTS:0NM7) Accounts Payable & Accrued Expense : €392 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Virbac Accounts Payable & Accrued Expense?

Virbac's quarterly accounts payable & accrued expense declined from Dec. 2023 (€337 Mil) to Jun. 2024 (€329 Mil) but then increased from Jun. 2024 (€329 Mil) to Dec. 2024 (€392 Mil).

Virbac's annual accounts payable & accrued expense increased from Dec. 2022 (€336 Mil) to Dec. 2023 (€337 Mil) and increased from Dec. 2023 (€337 Mil) to Dec. 2024 (€392 Mil).

Virbac Accounts Payable & Accrued Expense Historical Data

The historical data trend for Virbac's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Accounts Payable & Accrued Expense Chart

Virbac Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

269.22

311.05

335.53

337.34

392.06

Virbac Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															335.53	290.92	337.34	328.50	392.06

Virbac Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Virbac Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (LTS:0NM7) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

VRBCF:USA VIRPp:UK VIRP:France V16:Germany

Address

13e rue LID - BP 27, Carros, FRA, 06511

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.

Virbac Headlines

No Headlines